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Abstract
The decline in Avoidable Mortality (AM) and increase in life expectancy in Shanghai is impressive. Gusmano and 
colleagues suggested that Shanghai’s improved health system has contributed significantly to this decline in AM. 
However, when compared to other global cities, Shanghai’s life expectancy at birth is improving as London and New 
York City, but has yet to surpass that of Hong Kong, Tokyo, and Paris. Over the past decade, the reduction in AM of 
Shanghai is just in line with the international experience in reducing avoidable premature deaths. We suggest that a 
more elaborate research design is needed to examine the impact of the improvement in Shanghai’s health system on its 
population health status. 
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By studying the trend of Avoidable Mortality (AM) in Shanghai during 2000–10, Gusmano and colleagues (1) showed that there is a great reduction in AM 
among registered residents, and the speed of the decline is 
comparable to or even better than other global cities, such 
as New York City and Paris. As the avoidable deaths can be 
prevented by effective healthcare intervention, Gusmano and 
colleagues suggested that the decline of AM is largely due to 
improvement in Shanghai’s healthcare system. However, no 
empirical data was given to demonstrate a direct link for this 
causal relationship. 
Since 1998, when the Shanghai Municipal Center for 
Disease Control and Prevention was established, Shanghai’s 
healthcare system experienced several major reforms that 
have led to increased coverage of health insurance and 
enhanced accessibility to community-based healthcare 
services. According to the Statistical Bureau of Shanghai (2), 
in the last 15 years (i.e. 1998–2013) the life expectancy at birth 
has increased by 5.13 years for registered male residents, from 
75.06 years in 1998 to 80.19 years in 2013, but only increased 
3.91 years during 1983–98. The life expectancy at birth for 
registered female residents was 84.79 years in 2013, with an 
increase of 5.77 years in 1998-2013, compared to an increase of 
3.76 years in 1983-98. The life expectancy at birth of registered 
residents has greatly improved over the past three decades 
(i.e. 1983–2013). The improvement and the accelerated rate 
of increase since 1998 may be related to improvement of 
Shanghai’s health system. However, the improvement in life 
expectancy does not exclusively occur in Shanghai. Figures 
1 and 2 provide a cross-city comparison on the average life 
expectancy at birth of six global cities: Shanghai, New York 
City, London, Paris, Tokyo, and Hong Kong. Shanghai has 
lagged behind but has been catching up quickly in the past 
decade. In 1999, Shanghai’s male life expectancy at birth 
was 76.38 years, which was actually higher than London 
and New York City but lower than that of Tokyo and Hong 
Kong. During 1999–2013, Shanghai’s life expectancy at 
birth has continuously improved; and currently, the males’ 
life expectancy seems to converge with other global cities at 
the level of 80–81 years, except New York City (Figure 1). 
Shanghai’s female life expectancy has been keeping pace with 
London over the past decade; though ahead of New York City, 
it is currently falling behind Hong Kong, Tokyo, and Paris. 
Initially, the gap in life expectancy between Shanghai and 
some global cities such as Hong Kong, Tokyo, and Paris, was 
large but it has been narrowing (Figure 2). 
Does the improvement in Shanghai’s healthcare system 
contribute to the decline in AM as suggested by Gusmano 
and colleagues (1), as well as the increase in life expectancy 
of the registered population? It is far from conclusive. 
Further empirical data and better research design is needed 
to support their findings. Shanghai’s experience of falling 
AM and increasing longevity is very similar to that of other 
global cities. Furthermore, when analyzed within the context 
of the recent national or global trends, the trends witnessed 
by these highly-developed global cities, actually are not that 
exceptional. A global estimation on premature mortality 
(i.e. mortality under the age of 70) published in The Lancet 
(3) has shown that during 2000–10, China had a reduction 
of 19% in the premature mortality rate, with a reduction of 
36% in the 0–4 age group, 30% in the 5–49 age group, and 
15% in the 50–69 age group. And the global premature 
mortality rate decreased by 19%, with a decrease of 34% in 
the 0–4 age group, 17% in the 5–49 age group, and 15% in 
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the 50–69 age group. This implies that the whole world has 
also experienced dramatic decline in mortality over the last 
decade, especially in avoidable premature deaths. Meanwhile, 
in 2000–12 China’s suicide rate has significantly declined 
by more than 60% (4). This decline also contributes to the 
decrease of avoidable premature deaths and increase in 
life expectancy. But there are other suggested reasons for 
the suicide reduction, for example, the improvement of 
education and work opportunities due to urbanization, and 
improvement of quality of life, especially for rural women. 
Certainly, the improvement of the healthcare system would 
be able to provide a more timely and effective treatment to 
those who attempt suicide. 
The improvement in the health system might contribute to 
increase of lifespan but higher degree of disability is expected 
to appear among people in advanced age. A more challenging 
issue for our health system is to ascertain “are we living 
healthier, not only longer”. And what has not been explored in 
the paper of  Gusmano et al. (1) is that “whether the substantial 
investment in Shanghai’s health system has made its residents 
live in better health than before”. 
Measuring the improvement of the health system with only 
one indicator – AM, can be problematic and misleading to 
some extent. The improved health system may have raised the 
survival rate, but it could also have left more people living 
with disabilities and cause a large disease burden on the 
healthcare system. For instance, behind the rapid mortality 
decline in the 1970s, the U.S. also witnessed worsening 
health conditions among middle-aged and older people (5). 
In Europe, despite the increase in life expectancy, concerns 
grow that the health system will face increasing challenges 
as increasing old people suffer from cancer, diabetes, mental 
disorders (6). The changes in the population’s health status 
should also be included to appraise the performance of 
the health system (7,8). Gusmano and colleagues (1) have 
detected the decrease in avoidable deaths, but failed to reveal 
how morbidity changes behind the declining mortality and 
increasing life expectancy. As life expectancy increases, the 
incidence and the duration of suffering disease and disability 
may increase as well, leading to the morbidity expansion 
(9–11), which is termed “the failures of the success” by 
Gruenberg (9). Alternatively, Shanghai may have experienced 
a “morbidity compression” that the morbidity is compressed 
to a shorter and later period of the lifespan with increase 
in the Health-Adjusted Life Expectancy (HALE) (12). But 
until now, there has been little research on the healthiness of 
Shanghai’s population. 
Further investigation into morbidity trends is much needed 
for better health planning and management in these rapidly-
aging global cities. Due to the prolonged low fertility, the aging 
problem in Shanghai, Hong Kong, and Tokyo is probably 
more serious compared to other global cities in Western 
countries. In 2013 about 18% of Shanghai’s registered resident 
population were over age 65 (2) and about 14% of Hong 
Kong’s population were elderly (13). As a large proportion 
of the population will enter into old age in these cities, the 
increasing morbidity and disability among the elderly will 
lead to an increase in government expenditures on healthcare. 
Nowadays, the so-called “active aging” or “productive 
aging” is advocated widely and extending retirement age is 
suggested to increase the workforce (14). However, it should 
be emphasized that the prerequisite for the success of these 
strategies is healthy aging. Therefore, the trends in morbidity 
and disability rates among the elderly are the decisive factor 
in facing the aging issue. 
Apart from traditional indicators – mortality and life 
expectancy, further exploration on the HALE and Disability-
Adjusted Life-years (DALY) for Shanghai and other global 
cities is also called for. By combining mortality and morbidity, 
HALE and DALY can better reflect the health progress of 
Shanghai’s residents. Salomon and colleagues (7) conducted 
a systematic study on HALE for 187 countries. One of their 
important findings is that HALE increases more slowly than 
the life expectancy over the last 20 years. They estimate that 
an increase of one year in life expectancy is only accompanied 
by an increase of 10 months in HALE (7). They argue that 
the reduction of morbidity lags behind mortality decline for 
the past twenty years. The AM used by Gusmano et al. (1) 
can only reflect the health progress in reducing deaths. In 
terms of reducing morbidity and increasing HALE, it is still 
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Figure 1. The life expectancy at birth for males in six global cities.
Sources: Shanghai Statistical Bureau; The Department of Health 
and Mental Hygiene of New York City; Statistics and Information 
Department, Ministry of Health, Labor and Welfare, Japan; London 
Datastore; National Institute of Statistics and Economic Studies 
(INSEE), France; Census and Statistics Department of Hong Kong 
SAR.
Figure 2. The life expectancy at birth for females in six global cities.
Sources: Shanghai Statistical Bureau; The Department of Health 
and Mental Hygiene of New York City; Statistics and Information 
Department, Ministry of Health, Labor and Welfare, Japan; London 
Datastore; National Institute of Statistics and Economic Studies 
(INSEE), France; Census and Statistics Department of Hong Kong 
SAR.
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unknown whether Shanghai’s rising is still comparable to 
other global cities. 
Shanghai has been witnessing a great reduction in AM and 
an accelerated increase in life expectancy among registered 
residents. It is also of interest to learn about the situation for 
non-registered resident population (i.e. non hukou resident). 
As they may not be as well-covered by the healthcare system 
as registered residents, if they have similar improvement 
in AM and life expectancy, then we need to look for other 
factors which may have contributed to the improvement. 
Nevertheless, the possible contribution of improvement in the 
health system should be recognized but needs to be carefully 
evaluated. Future investigation and comparison in morbidity 
trends, HALE, and DALY will help assess impacts of the 
healthcare system on health progress more comprehensively. 
This will provide illuminating information on health 
management and planning, especially for these aging global 
cities.
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